Evidence map›Paper›PMID 19729449›Full record

ArticleThe Journal of biological chemistry2009

Glu-333 of nicastrin directly participates in gamma-secretase activity.

Daniel R Dries, Sanjiv Shah, Yu-Hong Han, Cong Yu, Sophie Yu, Mark S Shearman, Gang Yu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Nicastrin functions to sterically hinder γ-secretase-substrate interactions driven by substrate transmembrane domain.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Article
  15. Structural basis of human γ-secretase assembly.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  16. Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Structure of nicastrin unveils secrets of γ-secretase.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Crystal structure of the γ-secretase component nicastrin.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daniel R DriesDepartment of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Sanjiv Shah
Yu-Hong Han
Cong Yu
Sophie Yu
Mark S Shearman
Gang Yu
The University of Texas Southwestern Medical Center · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Biochemistry of Nicastrin in the Gamma-Secretase ComplexR01AG023104 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI YU, GANG · 2004 to 2008
$1.5M
Mechanism and Function of Sequential Proteolysis in Health and DiseaseR01AG029547 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI YU, GANG · 2007 to 2010
$1.1M
gamma-Secretase: The First Enzymology-Based Study of Intramembrane ProteolysisF32AG031625 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI DRIES, DANIEL R. · 2007 to 2009
$148k
NIA NIH HHS F32 AG031625NIA NIH HHS R01 AG023104NIA NIH HHS R01 AG029547
6 · The paper itself

Abstract

gamma-Secretase is a proteolytic membrane complex that processes a variety of substrates including the amyloid precursor protein and the Notch receptor. Earlier we showed that one of the components of this complex, nicastrin (NCT), functions as a receptor for gamma-secretase substrates. A recent report challenged this, arguing instead that the Glu-333 residue of NCT predicted to participate in substrate recognition only participates in gamma-secretase complex maturation and not in activity per se. Here, we present evidence that Glu-333 directly participates in gamma-secretase activity. By normalizing to the active pool of gamma-secretase with two separate methods, we establish that gamma-secretase complexes containing NCT-E333A are indeed deficient in intrinsic activity. We also demonstrate that the NCT-E333A mutant is deficient in its binding to substrates. Moreover, we find that the cleavage of substrates by gamma-secretase activity requires a free N-terminal amine but no minimal length of the extracellular N-terminal stub. Taken together, these studies provide further evidence supporting the role of NCT in substrate recognition. Finally, because gamma-secretase cleaves itself during its maturation and because NCT-E333A also shows defects in gamma-secretase complex maturation, we present a model whereby Glu-333 can serve a dual role via similar mechanisms in the recruitment of both Type 1 membrane proteins for activity and the presenilin intracellular loop during complex maturation.

Indexed as

Amino Acid SubstitutionAmyloid Precursor Protein SecretasesAnimalsCell LineGlutamic AcidHumansMembrane GlycoproteinsMutation, MissenseProtein BindingProtein Processing, Post-TranslationalProtein Structure, SecondarySpodopteraSubstrate SpecificityAmyloid Precursor Protein SecretasesGlutamic AcidMembrane Glycoproteinsnicastrin protein

Identifiers

PMID19729449
PMCPMC2785603
OpenAlexW1976240009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.